Mando Group AB has developed a non-invasive treatment for eating disorders and a weight loss treatment that is based on 25 years of clinical research in collaboration with the Karolinska Institute in Stockholm.
Mando Group AB is a privately owned healthcare company with six clinics in three countries.
We treat weight loss and eating disorders with the aid of the patented Mandometer® medical device.
The treatment is based on scientific evidence obtained in randomized controlled clinical trials, which demonstrated its effectiveness in treating eating disorders and obesity. 75% of eating disorders patients go into remission in about a year, only 10% relapse over five years of follow-up.
Mandolean treatment is more effective than a standard weight loss program. With the Mandometer medical device, the weight loss is maintained, and biological signals for hunger and fullness are re-established.
Mandometer treatment is a standard treatment in Sweden for eating disorders since 1997. Mandometer treatment is available in Australia, the United States and Sweden and the 90 people who are employed in the company have brought 1400 eating disorders patients into remission, reducing public spending by some €560 million.
Mando Group was started by Dr Cecilia Bergh and Professor Per Södersten, after many years of research devoted to understanding eating behavior and satiety at the Karolinska Institutet, Sweden’s foremost medical school.
Cecilia Bergh, PhD
Cecilia Bergh became interested in eating disorders at the beginning of the 1980’s and wrote her doctoral thesis about bulimia. Together with Per Södersten, she has developed the treatment method that is used today at the Mandometer and the Mandolean Clinics. Today Cecilia Bergh is CEO of Mando Group AB.
Per Södersten, Professor
Per Södersten is professor at the Section for Applied Neuroendocrinology at the Karolinska Institutet in Stockholm, Sweden and Director of Research and Development for the Mando Group AB. Through his research, Per Södersten began to understand the special problems that affect people with eating disorders and overweight.
Torbjörn Hultsberg is a business lawyer and a partner at the American law firm Kilpatrick, Townsend & Stockton´s Stockholm office. He has experience from boards both in public and private companies.
Board Member and CEO Mando Group AB
Cecilia Bergh, PhD, one of Mando Group’s founders. She has built up the company together with Per Södersten following many years of research concerning eating behavior and satiety at the Karolinska Institutet. Cecilia Bergh is a board member of the Swedish Entrepreneurship Forum.
Eva Krutmeijer is a senior science communicator and owner of EKKO AB, a consulting company focused on bridging newly acquired knowledge with decision making at different levels for a knowledge-based and sustainable society.
Eva Krutmeijer has an academic background in physical chemistry and has served as head of information at The Royal Swedish Academy of Sciences.
Björn Meister, MD and PhD, is a professor at the Department of Neuroscience, Karolinska Institutet. His research is focused on brain control of food intake and body weight.
Per Södersten is one of Mando Group AB’s founders.
He is a professor, head of Section of Applied Neuroendocrinology at the Karolinska Institutet and at the same time Director of R&D at Mando Group AB.